NCT02960711View on ClinicalTrials.gov

Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

1,600

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

July 31, 2019

Study Completion Date

July 31, 2019

Conditions

Metabolic Syndrome

Interventions

DRUG

Metformin Hydrochloride 850 MG Oral Tablet [Glucophage]

DRUG

Ludipress, mg stereate, micronized hydrated silica, talcum

Tablet

Trial Locations (1)

20133

Fondazione IRCCS Istituto Nazionale Tumori, Milan

All Listed Sponsors

lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER

NCT02960711 - Metformin and Dietary Restriction to Prevent Age-related Morbid Events in People With Metabolic Syndrome | Biotech Hunter | Biotech Hunter